© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 370,524 results that match your search.370,524 results
  • Greece is hoping to become a frequent presence in the capital markets with a syndicated bond issuance every three months, according to the head of the sovereign's Public Debt Management Agency.
  • Dutch release liner manufacturer Loparex is launching a €186m term loan B to refinance the equity bridge, put in place by sponsor Pamplona when the company acquired its competitor Infiana last autumn. While the borrowing conditions are exceptionally benign for many, Loparex has struggled to make a good first impression.
  • It has been the busiest start to the year on record for both CEEMEA and emerging market bonds globally, and the enthusiastic printing shows little sign of abating. New issues in the secondary market have mostly performed strongly, and high redemption volumes this year will have investors flush with cash.
  • UK soft drinks company Britvic has entered the US private placement (USPP) market via Rabobank and Santander, on the hunt for sterling debt. As the issuer is a regular and well-loved borrower among institutional investors, the transaction has been described by one banker as “as easy as they come.”
  • RBS has sold a risk transfer securitization referencing a book of UK green project finance loans to the BAE Systems pension fund, which was advised by a unit of Macquarie. The deal is the first ESG-rated risk transfer deal in the UK, and also potentially the longest-dated risk transfer deal ever done in the UK, with an average life of eight to nine years.
  • DBV Technologies, the French biopharmaceuticals company that specialises in treating allergies, has successfully completed a $153m growth capital raise, despite market volatility earlier in the week owing to fears over the spread of corona virus in Asia.
  • The coronavirus outbreak has created a rush to safe haven assets. While the demand for SSA paper is hotter than ever, some feared that sharply falling yields would make the primary market less attractive. However, borrowers have proved those worries unfounded by building big order books for new bonds this week.
  • Elenia, the Finish electricity distribution company, opened books for a €500m no-grow seven-year bond on Thursday, its first issue since Standard & Poor’s upgraded it to BBB+ in November.
  • Tikehau Capital has taken over a US high yield fund formerly managed by Semper Capital Management, bringing over the portfolio managers that run it as well. It is part of the firm’s plan to rebalance its business and boost its liquid strategies offering.
  • The Loan Market Association is set to restart its Schuldschein working group in February, with a workstream addressing credit restructuring. This is an early sign that the market’s heavyweights are taking this issue — which has damaged the Schuldschein’s reputation in some quarters — seriously.
  • European equity capital markets’ buoyant start to the year ground to a halt this week as banks held back from doing deals over concerns about the outbreak of a deadly strain of coronavirus in China and how it may damage investor risk appetite. Losses in Asian markets, which are reopening following the Lunar New Year holiday, have compounded fears that global risk sentiment may be turning.
  • The Gabonese Republic has released price guidance on its first benchmark Eurobond since 2015.